Ansell stock

ANN · ASX · AUD

Compare Ansell
$45.91Change from previous close: −0.39%Absolute change: −$0.18

Close · November 20, 2026

Price history

+28.38% over the period

1 year: from $35.76 (November 20, 2025) to $45.91 (November 20, 2026), +28.38%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$45.91
October 30, 2026$45.44
September 30, 2026$45.27
August 31, 2026$40.77
July 31, 2026$32.79
June 30, 2026$31.74
May 29, 2026$27.85
April 30, 2026$26.42
March 31, 2026$28.23
February 27, 2026$32.46
January 30, 2026$32.64
December 31, 2025$35.01
November 28, 2025$37.49
November 20, 2025$35.76

At a glance

  • The company

    Designs, manufactures and distributes hand and body protection solutions for healthcare and industrial applications globally

  • Latest results

    Quarter to June 30, 2025 · EPS $0.32 (estimate $0.57)

TickerLandia's take on Ansell

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$25.05
52-wk high$47.19

−2.71% from the 52-week high

Analysts · 11 analysts

Average target$41.96−8.61% vs. price

Buy 1 · Hold 8 · Sell 2 · Hold

TickerLandia Fingerprint: Ansell

Compared with similar companies: very strong momentum and very high growth.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Ansell is cheaper than similar companies

Ansell's P/E (trailing 12 months): 21.6, −18% against the median of a group of 10 similar companies (26.2).

Compared with 10 similar companies

Ansell's metrics compared with similar companies
MetricAnsellPosition in the groupBand
P/E (trailing 12 months)21.6Low
Forward P/E18.3Low
Operating margin15.0%Middle
ROE10.5%Middle
Debt/equity0.37Middle

Grey band: the middle half of the group; tick: the median; dot: Ansell. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$1.11B

Latest quarter · Q2 2026

Net income

$119.8M

Latest quarter · Q2 2026

Quarterly net margin

10.8%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$6.46B
P/E
21.6
EPS
$2.13
Volume
411.21K
Daily trading
€16.13M
Dividend yield
2.08%
Last ex-dividend on August 31, 2026

How Ansell is changing

All results
  • Revenue grew 1.1% a year on average over the last 5 years

  • Operating margin rose from 12.6% to 15.0%

  • Profits turn into cash: free cash flow equal to 187% of net income

Returns

Ansell returns with dividends

$1,000 invested in Ansell 5 years ago, on November 22, 2021, would be worth $1,654 today with dividends reinvested: +65.35% in total, +10.59% per year. On price alone it would be $1,457 (+45.65%).

PeriodAnsellS&P/ASX 200$1,000 becomes
1 month−0.37%−2.54%$996
6 months+79.76%+1.13%$1,798
Year to date+31.13%−1.40%$1,311
1 year+31.73%+0.47%$1,317
3 years+114.31%+21.74%$2,143
5 years+65.35%+16.86%$1,654
10 years+169.66%+60.57%$2,697

Over the last 6 months it has done better than 100% of the stocks in the Industrials sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment

The chart in detail

Ansell: technical analysis

Ansell is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 2.2% below its highest close since January 1, 1990 ($46.95, November 12, 2026).

Trend
Upward
RSI (14 sessions)
53
Between 30 and 70
vs 200-session average
+32.64%

Support and resistance

Price areas where Ansell has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$46.98+2.33%2 touches, last on November 12, 2026
  2. Last price$45.91
  3. Support$42.59−7.24%2 touches, last on September 4, 2026
  4. Support$34.47−24.93%2 touches, last on January 22, 2026
  5. Support$33.05−28.01%4 touches, last on July 6, 2026

Volatility and risk

Over the last year it has moved roughly in line with the S&P/ASX 200.

Beta (1 year) vs S&P/ASX 200
1.01
Volatility (60 sessions, annualised)
17.2%
Largest fall in the last year
−33.18%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Ansell: seasonality

Average monthly price change over 37 years

−1.0%Jan−2.6%Feb+0.7%Mar+0.7%Apr+0.3%May−1.1%Jun+1.3%Jul+3.1%Aug+0.1%Sep+1.0%Oct+1.5%Nov+1.2%Dec

Over the last 37 years, the strongest month for Ansell has been August: +3.08% on average, positive in 23 years out of 37. The weakest has been February: −2.58% on average, positive in 12 years out of 36. November, the current month, has been positive in 23 years out of 36 (+1.46% on average).

Show chart data
MonthAverageMedianPositive years
January−1.00%−0.53%15 of 35
February−2.58%−1.94%12 of 36
March+0.69%+0.27%19 of 36
April+0.73%+0.12%18 of 36
May+0.31%−1.23%17 of 36
June−1.06%−0.30%17 of 36
July+1.33%+2.38%22 of 36
August+3.08%+2.61%23 of 37
September+0.06%−0.44%18 of 37
October+1.05%+0.45%22 of 37
November+1.46%+1.95%23 of 36
December+1.19%+1.06%19 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Ansell and its competitors

Ansell, based in Richmond, Australia, was founded in 1893 and was formerly known as Pacific Dunlop Limited before adopting its current name in 2002. The company makes hand and body protection products sold to healthcare and industrial customers across Asia Pacific, Europe, the Middle East, Africa, Latin America and North America. Its Healthcare segment supplies surgical and examination gloves, operating room consumables and sterile garments to hospitals, dental practices, laboratories and pharmaceutical companies. The Industrial segment offers chemical protective clothing for sectors such as automotive, mining, oil and gas and food.

Headquarters
Richmond, Australia
Employees
15,000
Founded
1893
Chief executive
Nathalie Ahlstrom
Ansell and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
AnsellANN$4.31B15.0%21.6+79.76%
Lenskart SolutionsLENSKART$13.82B10.5%163.9+51.79%
Fisher And Paykel Healthcare CorpoFPH$15.85B27.6%57.7+47.73%
Resmed CdiRMD$33.23B34.0%22.3+21.12%
HOYA7741$47.84B34.4%27.3−13.64%
Fielmann GroupFIE$3.93B13.7%16.4−3.95%

Same industry or related industries, similar size. Compare Ansell with its competitors · Full profile